Currency In USD
| Previous Close | 3 |
| Open | 2.93 |
| Day High | 2.93 |
| Day Low | 2.77 |
| 52-Week High | 5.08 |
| 52-Week Low | 2.25 |
| Volume | 128,115 |
| Average Volume | 149,062 |
| Market Cap | 121.74M |
| PE | -14.45 |
| EPS | -0.2 |
| Moving Average 50 Days | 2.73 |
| Moving Average 200 Days | 3.56 |
| Change | -0.11 |
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026
GlobeNewswire Inc.
Feb 25, 2026 2:00 PM GMT
CLEARWATER, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
GlobeNewswire Inc.
Feb 18, 2026 1:00 PM GMT
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GlobeNewswire Inc.
Jan 29, 2026 1:00 PM GMT
CLEARWATER, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ